Towa Pharmaceutical
4553.TPhase 2Towa Pharmaceutical is a major Japanese generic drug manufacturer with a mission to contribute to public health by supplying stable, high-quality, and affordable generic medicines. The company has established a strong market position in Japan through its extensive portfolio of generic products and its manufacturing capabilities. Its strategic direction includes expanding its product lineup, enhancing production efficiency, and exploring opportunities in biosimilars and other advanced generic segments. As a publicly traded entity, it operates with a focus on sustainable growth and shareholder returns.
4553.T · Stock Price
Historical price data
AI Company Overview
Towa Pharmaceutical is a major Japanese generic drug manufacturer with a mission to contribute to public health by supplying stable, high-quality, and affordable generic medicines. The company has established a strong market position in Japan through its extensive portfolio of generic products and its manufacturing capabilities. Its strategic direction includes expanding its product lineup, enhancing production efficiency, and exploring opportunities in biosimilars and other advanced generic segments. As a publicly traded entity, it operates with a focus on sustainable growth and shareholder returns.
Technology Platform
Integrated generic drug development and manufacturing platform focused on formulation science, analytical chemistry, and bioequivalence testing to produce high-quality, affordable alternatives to off-patent branded medicines.
Pipeline Snapshot
11 drug in pipeline
| Drug | Indication | Stage |
|---|---|---|
| Bromocriptine Mesilate + Placebos | Familial Alzheimer Disease (FAD) | Phase 1/2 |
Funding History
1Opportunities
Risk Factors
Competitive Landscape
Towa competes with other major Japanese generic firms like Sawai Pharmaceutical and Nippon Chemiphar, as well as global players. Its differentiation is based on a strong domestic manufacturing footprint, a broad product portfolio, and a reputation for reliable quality and supply in the Japanese market.
Company Info
Trading
Contact
Therapeutic Areas
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile